Canopy Growth Corporation (CGC)
USD 2.83
(-7.21%)
USD 2.83
(-7.21%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 497.69 Million USD | -20.98% |
| 2022 | 629.87 Million USD | -13.12% |
| 2021 | 724.98 Million CAD | 69.27% |
| 2020 | 428.31 Million CAD | 163.23% |
| 2019 | -677.35 Million CAD | 55.87% |
| 2018 | -1.53 Billion CAD | -388.59% |
| 2017 | -314.13 Million CAD | -243.43% |
| 2016 | -91.47 Million CAD | -704.13% |
| 2015 | -11.37 Million CAD | -191.75% |
| 2014 | -3.89 Million CAD | -90.25% |
| 2013 | -2.04 Million CAD | -19899.78% |
| 2012 | -10.24 Thousand CAD | 53.26% |
| 2011 | -21.92 Thousand CAD | -128.96% |
| 2010 | -9576.00 CAD | 74.79% |
| 2009 | -37.98 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 315.2 Million USD | -15.89% |
| 2023 Q4 | 378.6 Million USD | -31.23% |
| 2023 Q3 | 550.52 Million USD | 4.9% |
| 2023 Q2 | 524.78 Million USD | -12.78% |
| 2023 Q1 | 601.69 Million USD | -4.47% |
| 2023 FY | 497.69 Million USD | -20.98% |
| 2022 Q1 | 688.22 Million CAD | -5.07% |
| 2022 FY | 629.87 Million USD | -13.12% |
| 2022 Q4 | 629.87 Million USD | 3.69% |
| 2022 Q3 | 607.47 Million CAD | 0.01% |
| 2022 Q2 | 607.39 Million CAD | -11.74% |
| 2021 Q3 | 1.03 Billion CAD | 44.4% |
| 2021 Q2 | 718.98 Million CAD | -36.43% |
| 2021 Q4 | 724.98 Million CAD | -30.17% |
| 2021 Q1 | 1.13 Billion CAD | 164.06% |
| 2021 FY | 724.98 Million CAD | 69.27% |
| 2020 Q3 | -55.32 Million CAD | 60.36% |
| 2020 Q1 | -340.14 Million CAD | 49.78% |
| 2020 Q2 | -139.59 Million CAD | 58.96% |
| 2020 FY | 428.31 Million CAD | 163.23% |
| 2020 Q4 | 428.31 Million CAD | 874.11% |
| 2019 Q4 | -677.35 Million CAD | 32.53% |
| 2019 Q3 | -1 Billion CAD | -101.6% |
| 2019 Q1 | -1.01 Billion CAD | 34.14% |
| 2019 FY | -677.35 Million CAD | 55.87% |
| 2019 Q2 | -497.97 Million CAD | 50.74% |
| 2018 FY | -1.53 Billion CAD | -388.59% |
| 2018 Q4 | -1.53 Billion CAD | 53.83% |
| 2018 Q2 | 480.75 Million CAD | 1378.34% |
| 2018 Q3 | -3.32 Billion CAD | -791.48% |
| 2018 Q1 | -37.6 Million CAD | 88.03% |
| 2017 Q2 | -98.63 Million CAD | 6.58% |
| 2017 Q4 | -314.13 Million CAD | -37.23% |
| 2017 FY | -314.13 Million CAD | -243.43% |
| 2017 Q1 | -105.58 Million CAD | -15.43% |
| 2017 Q3 | -228.91 Million CAD | -132.08% |
| 2016 Q2 | -37.93 Million CAD | -146.36% |
| 2016 FY | -91.47 Million CAD | -704.13% |
| 2016 Q4 | -91.47 Million CAD | -7.19% |
| 2016 Q3 | -85.33 Million CAD | -124.94% |
| 2016 Q1 | -15.39 Million CAD | -35.38% |
| 2015 Q4 | -11.37 Million CAD | 27.75% |
| 2015 Q2 | -1.82 Million CAD | 86.24% |
| 2015 FY | -11.37 Million CAD | -191.75% |
| 2015 Q1 | -13.27 Million CAD | 32.03% |
| 2015 Q3 | -15.74 Million CAD | -761.76% |
| 2014 Q1 | -10.37 Million CAD | -35.43% |
| 2014 Q3 | -3.89 Million CAD | 53.35% |
| 2014 Q2 | -8.35 Million CAD | 19.44% |
| 2014 Q4 | -19.53 Million CAD | -400.91% |
| 2014 FY | -3.89 Million CAD | -90.25% |
| 2013 Q3 | -418.75 Thousand CAD | -2663.33% |
| 2013 Q1 | -10.24 Thousand CAD | 15.21% |
| 2013 FY | -2.04 Million CAD | -19899.78% |
| 2013 Q2 | -15.15 Thousand CAD | -47.89% |
| 2013 Q4 | -7.66 Million CAD | -1729.32% |
| 2012 Q4 | -12.08 Thousand CAD | 20.95% |
| 2012 FY | -10.24 Thousand CAD | 53.26% |
| 2012 Q1 | -21.92 Thousand CAD | -0.16% |
| 2012 Q2 | -890.00 CAD | 95.94% |
| 2012 Q3 | -15.28 Thousand CAD | -1617.75% |
| 2011 Q4 | -21.89 Thousand CAD | 37.55% |
| 2011 FY | -21.92 Thousand CAD | -128.96% |
| 2011 Q1 | -9576.00 CAD | 2.69% |
| 2011 Q2 | -9510.00 CAD | 0.69% |
| 2011 Q3 | -35.05 Thousand CAD | -268.62% |
| 2010 Q2 | -31.12 Thousand CAD | 18.07% |
| 2010 FY | -9576.00 CAD | 74.79% |
| 2010 Q4 | -9841.00 CAD | 42.93% |
| 2010 Q3 | -17.24 Thousand CAD | 44.6% |
| 2010 Q1 | -37.98 Thousand CAD | -162.3% |
| 2009 FY | -37.98 Thousand CAD | 0.0% |
| 2009 Q4 | -14.48 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Theratechnologies Inc. | 24.87 Million USD | -1901.122% |
| Harrow Health, Inc. | 116.41 Million USD | -327.514% |
| Dynavax Technologies Corporation | 106.63 Million USD | -366.731% |
| Biofrontera Inc. | 4.05 Million USD | -12170.685% |
| Cronos Group Inc. | -663.32 Million USD | 175.031% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 19849.96% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 20.162% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 3515.447% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 9696.915% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -465653.002% |
| Radius Health, Inc. | 359.28 Million USD | -38.526% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -252271.342% |
| DURECT Corporation | -7.65 Million USD | 6602.469% |
| ProPhase Labs, Inc. | 19.23 Million USD | -2488.004% |
| Safety Shot Inc | -2.28 Million USD | 21887.097% |
| Phibro Animal Health Corporation | 454.84 Million USD | -9.421% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 5377.976% |
| Alvotech | 1.06 Billion USD | 53.238% |
| Assertio Holdings, Inc. | -32.52 Million USD | 1630.016% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 1584.472% |
| Rockwell Medical, Inc. | 4.45 Million USD | -11069.188% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 3283.309% |
| Procaps Group S.A. | 242.93 Million USD | -104.872% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 480.419% |
| SCYNEXIS, Inc. | -19.35 Million USD | 2672.088% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 10305.024% |
| Viatris Inc. | 17.13 Billion USD | 97.095% |
| OptiNose, Inc. | 58.06 Million USD | -757.141% |
| SIGA Technologies, Inc. | -148.68 Million USD | 434.741% |
| Tilray Brands, Inc. | 158.97 Million USD | -213.064% |
| PetIQ, Inc. | 351.93 Million USD | -41.419% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 3283.309% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | -180.71% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 7925.892% |
| Alimera Sciences, Inc. | 55.3 Million USD | -799.852% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | -14.325% |
| Silver Spike Investment Corp. | -32.61 Million USD | 1626.139% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 33531.292% |
| Organogenesis Holdings Inc. | 15.01 Million USD | -3215.12% |
| Journey Medical Corporation | -9.7 Million USD | 5226.161% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 9935.202% |
| Alpha Teknova, Inc. | 1.97 Million USD | -25112.715% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 10438.575% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | -308.291% |
| PainReform Ltd. | -7.95 Million USD | 6360.365% |
| Cosmos Health Inc. | 8.59 Million USD | -5693.424% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | -11702.205% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -13431.784% |
| Embecta Corp. | 1.31 Billion USD | 62.066% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 17253.588% |
| Talphera, Inc. | -5.72 Million USD | 8799.511% |
| Pacira BioSciences, Inc. | 432.74 Million USD | -15.009% |
| Incannex Healthcare Limited | -5.48 Million USD | 9173.82% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 6159.541% |
| Shineco, Inc. | 29.29 Million USD | -1599.194% |
| Procaps Group, S.A. | 242.93 Million USD | -104.872% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | -428.304% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | -564.041% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 614.63% |
| Alvotech | 1.06 Billion USD | 53.238% |
| Hempacco Co., Inc. | 13.61 Million USD | -3555.606% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | -6865.696% |
| Bright Green Corporation | 1.84 Million USD | -26923.539% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | -8.502% |
| Kamada Ltd. | -46.43 Million USD | 1171.899% |
| Indivior PLC | -33.95 Million USD | 1565.89% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -190901.021% |
| Flora Growth Corp. | -713 Thousand USD | 69903.506% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 6159.541% |
| Evolus, Inc. | 63.7 Million USD | -681.219% |
| HUTCHMED (China) Limited | -197.45 Million USD | 352.053% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | -3.88% |
| Akanda Corp. | 3.9 Million USD | -12645.447% |